MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

  1. Monk, B.J.
  2. Grisham, R.N.
  3. Banerjee, S.
  4. Kalbacher, E.
  5. Mirza, M.R.
  6. Romero, I.
  7. Vuylsteke, P.
  8. Coleman, R.L.
  9. Hilpert, F.
  10. Oza, A.M.
  11. Westermann, A.
  12. Oehler, M.K.
  13. Pignata, S.
  14. Aghajanian, C.
  15. Colombo, N.
  16. Drill, E.
  17. Cibula, D.
  18. Moore, K.N.
  19. Christy-Bittel, J.
  20. del Campo, J.M.
  21. Berger, R.
  22. Marth, C.
  23. Sehouli, J.
  24. O’Malley, D.M.
  25. Churruca, C.
  26. Boyd, A.P.
  27. Kristensen, G.
  28. Clamp, A.
  29. Ray-Coquard, I.
  30. Vergote, I.
  31. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2020

Alea: 38

Zenbakia: 32

Orrialdeak: 3753-3762

Mota: Artikulua

DOI: 10.1200/JCO.20.01164 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus